Cladis Investment Advisory, LLC
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1911520
BILLINGS, MT
Position in CPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
10,020
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cladis Investment Advisory, LLC holds $620,266 across 3 Biotechnology names. CPRX ranks #3 (0.0% of the industry book) .
All Filings in CPRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 10,020 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | — | 10,020 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 10,020 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | — | 10,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | — | 10,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | — | 10,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | — | 10,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2023-12-31 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2023-09-30 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2023-06-30 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2023-03-31 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2022-12-31 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2022-09-30 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2022-06-30 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2022-03-31 | — | 10,000 | Shares | Sole | 2024-10-09 | |
| 2021-12-31 | — | 10,000 | Shares | Sole | 2024-10-01 | |
| No filing history on record for this holder in this stock. | ||||||